4th Quarter - Report

EMERGENT BIOSOLUTIONS INC. for EMERGENT BIOSOLUTIONS INC

Period 4th Quarter 2022 Filed Jan 18, 2023 Signed by CHRISTOPHER FRECH

Official filing
Firm
EMERGENT BIOSOLUTIONS INC.
Client
EMERGENT BIOSOLUTIONS INC
Income
—
Expenses
$640,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Homeland Security HOM

NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.2617 - Consolidated Appropriations Act, 2023 (Omnibus) H.R.1437 - Further Continuing Appropriations and Extensions Act State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366; S.1457 - Stop Fentanyl Act H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R.7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act

LobbyistCovered position, as disclosed
CHRIS FRECH —
KATHERINE GETTY —
JILL HAMAKER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; White House Office; Health & Human Services, Dept of (HHS)

Bills named: H.R. 3263 (117th), S. 3799 (117th), H.R. 4341 (117th), H.R. 2379 (117th), H.R. 1437 (117th), S. 987 (117th), H.R. 2366 (117th), S. 1457 (117th), H.R. 7666 (117th), H.R. 2617 (117th), H.R. 7681 (117th)

Disaster Planning/Emergencies DIS

NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.2617 - Consolidated Appropriations Act, 2023 (Omnibus) H.R.1437 - Further Continuing Appropriations and Extensions Act State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366; S.1457 - Stop Fentanyl Act H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R.7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act

LobbyistCovered position, as disclosed
CHRIS FRECH —
KATHERINE GETTY —
JILL HAMAKER —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; White House Office; SENATE

Bills named: H.R. 3263 (117th), H.R. 2617 (117th), S. 3799 (117th), H.R. 2366 (117th), H.R. 2379 (117th), H.R. 1437 (117th), H.R. 7681 (117th), S. 1457 (117th), H.R. 7666 (117th), S. 987 (117th), H.R. 4341 (117th)

Budget/Appropriations BUD

NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.2617 - Consolidated Appropriations Act, 2023 (Omnibus) H.R.1437 - Further Continuing Appropriations and Extensions Act State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366; S.1457 - Stop Fentanyl Act H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R.7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act

LobbyistCovered position, as disclosed
CHRIS FRECH —
KATHERINE GETTY —
JILL HAMAKER —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; White House Office

Bills named: S. 1457 (117th), S. 987 (117th), H.R. 2379 (117th), H.R. 7666 (117th), H.R. 7681 (117th), H.R. 2366 (117th), H.R. 3263 (117th), H.R. 4341 (117th), S. 3799 (117th), H.R. 2617 (117th), H.R. 1437 (117th)

Health Issues HCR

NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.2617 - Consolidated Appropriations Act, 2023 (Omnibus) H.R.1437 - Further Continuing Appropriations and Extensions Act State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366; S.1457 - Stop Fentanyl Act H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R.7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act H.R.3263 Outreach - DHS Medical Countermeasures Act

LobbyistCovered position, as disclosed
CHRIS FRECH —
KATHERINE GETTY —
JILL HAMAKER —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); SENATE

Bills named: H.R. 4341 (117th), H.R. 3263 (117th), H.R. 2617 (117th), S. 987 (117th), H.R. 7681 (117th), H.R. 2379 (117th), H.R. 2366 (117th), H.R. 7666 (117th), H.R. 1437 (117th), S. 3799 (117th), S. 1457 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.